← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2014Last known activity
May 9, 2024
Timeline
1970s
- Jun 1, 1978
Taejoon Pharm Co., Ltd.— Founded
Drugs by trial phase (13 distinct, 14 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT06609525Lead sponsorPhase 2/Phase 3May 9, 2024
- NCT05967117CollaboratorPhase 4Nov 24, 2023
- NCT06287606Lead sponsorPhase 3Aug 29, 2023
- NCT06427031Lead sponsorPhase 3Jul 14, 2023
- NCT05870553Lead sponsorPhase 3Jan 30, 2023
- NCT05670470Lead sponsorPhase 3Sep 21, 2022
- NCT06876116CollaboratorPhase 4Sep 1, 2022
- NCT05346783Lead sponsorPhase 1/Phase 2Oct 14, 2021
- NCT05262179Lead sponsorPhase 1Oct 5, 2021
- NCT05245604Lead sponsorPhase 3Jun 19, 2020
- NCT04127851Lead sponsorPhase 4Nov 30, 2019
- NCT04164459Lead sponsorPhase 4Dec 19, 2018
- NCT03419975Lead sponsorPhase 3Apr 26, 2016
- NCT02461719Lead sponsorPhase 3Jan 1, 2014
Details
- Founded
- Seoul, KR Jun 1, 1978
- Last known activity
- May 9, 2024